There is a synergistic relationship between epilepsy and intellectual disability (ID), and the approach to managing people with these conditions needs to be holistic. Epilepsy is the main co-morbidity associated with ID, and clinical presentation tends to be complex, associated with higher rates of treatment resistance, multi-morbidity and premature mortality. Despite this relationship, there is limited level 1 evidence to inform treatment choice for this vulnerable population.
View Article and Find Full Text PDFClimate-related disasters pose significant risks to mental health and well-being globally. Individuals from disaster-prone regions, such as Puerto Rico, are at even greater risk. The devastating effects of recurrent hurricanes, compounded with pre-existing structural disparities (e.
View Article and Find Full Text PDFIntroduction: Teclistamab, the first approved B-cell maturation antigen-directed bispecific antibody for treatment of triple-class exposed relapsed/refractory multiple myeloma, demonstrated deep, durable responses with a manageable safety profile in the pivotal MajesTEC-1 cohort (NCT03145181/NCT04557098). Efficacy, safety, and pharmacokinetics from the MajesTEC-1 China cohort are reported.
Methods: Patients received teclistamab 1.
Infertility is often thought of as a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular, unprotected sexual intercourse. However, as fertility rates rapidly decline worldwide, we observe that the inability to conceive and have children stems not only from anatomical, physiological, or genetic conditions within the body but also from social, structural, and environmental conditions in society. Drawing on a wide array of international and interdisciplinary scholarship, this article rethinks infertility by focusing on the social, structural, and environmental conditions hindering the ability of individuals and couples to have children and become parents.
View Article and Find Full Text PDF